2009 Annual Meeting

Session: 13 QbD in Bio Process Development and Operation

Chair

Ron Taticek, Genentech, Inc.

Presentations

12:30 PM

(233a) QbD for Biotherapeutics: Opportunities and Challenges -- An Industrial View Point
Stefanie Pluschkell

12:55 PM

(233b) A Systems Approach for Design of Intensified Bio-Pharmaceutical Processes
Alicia Román Martínez

01:20 PM

(233c) Upstream Process Characterization Utilizing Response Surface Experimental Design: Case Study for a GS-NS0 Monoclonal Antibody Production Process
Serena Fries Smith, Edith Senderak, Rachel Bareither, Melanie Tellers, Vanessa Parikh, T. Craig Seamans, Michel Chartrain

01:45 PM

(233d) Characterization of Monoclonal Antibody Primary Recovery and Purification Steps: Towards Process Validation
Michael Iammarino, Nihal Tugcu, Joseph Nti-Gyabaah, Martin Chandler, David Roush

02:10 PM

(233e) Improving the Batch Cycle in Bioreactors: From Media Makeup to Cleaning
Gary Montague